Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis

Loading...
Thumbnail Image

Authors

Zhang, Yan
Zhou, Yuan
van der Mei, Ingrid A. F.
Simpson, Steve
Ponsonby, Anne-Louise
Lucas, Robyn
Tettey, Prudence
Charlesworth, Jac C.
Kostner, Karam
Taylor, B. V.

Journal Title

Journal ISSN

Volume Title

Publisher

BMJ Publishing Group

Abstract

Objective To investigate whether lipid-related or body mass index (BMI)–related common genetic polymorphisms modulate the associations between serum lipid levels, BMI and disability progression in multiple sclerosis (MS). Methods The association between disability progression (annualised Expanded Disability Status Scale (EDSS) change over 5 years, ΔEDSS) and lipid-related or BMI-related genetic polymorphisms was evaluated in a longitudinal cohort (n=184), diagnosed with MS. We constructed a cumulative genetic risk score (CGRS) of associated polymorphisms (p<0.05) and examined the interactions between the CGRS and lipid levels (measured at baseline) in predicting ΔEDSS. All analyses were conducted using linear regression. Results Five lipid polymorphisms (rs2013208, rs9488822, rs17173637, rs10401969 and rs2277862) and one BMI polymorphism (rs2033529) were nominally associated with ΔEDSS. The constructed lipid CGRS showed a significant, dose-dependent association with ΔEDSS (ptrend=1.4×10−6), such that participants having ≥6 risk alleles progressed 0.38 EDSS points per year faster compared with those having ≤3. This CGRS model explained 16% of the variance in ΔEDSS. We also found significant interactions between the CGRS and lipid levels in modulating ΔEDSS, including high-density lipoprotein (HDL; pinteraction=0.005) and total cholesterol:high-density lipoprotein ratio (TC:HDL; pinteraction=0.030). The combined model (combination of CGRS and the lipid parameter) explained 26% of the disability variance for HDL and 27% for TC:HDL. Interpretation In this prospective cohort study, both lipid levels and lipid-related polymorphisms individually and jointly were associated with significantly increased disability progression in MS. These results indicate that these polymorphisms and tagged genes might be potential points of intervention to moderate disability progression.

Description

Keywords

Citation

Zhang Y, Zhou Y, van der Mei IAF Ausimmune/AusLong Investigators Group, et al Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis Journal of Neurology, Neurosurgery & Psychiatry 2019;90:636-641.

Source

Journal of Neurology, Neurosurgery & Psychiatry

Book Title

Entity type

Access Statement

Open Access

License Rights

Restricted until